LAUREN RACKERS: Open Payments
NPI 1134890866 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,954 in 64 payments from 33 companies in 2025. Trend: 2023 $435 · 2024 $3,010 · 2025 $1,954
Food & beverage: $1,275Education: $678
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $243 |
| Lilly USA, LLC | 4 | $171 |
| SOBI, INC | 4 | $166 |
| ABBVIE INC. | 3 | $149 |
| Merck Sharp & Dohme LLC | 6 | $139 |
| Astellas Pharma US Inc | 2 | $108 |
| Incyte Corporation | 1 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $78 |
| PFIZER INC. | 4 | $75 |
| Janssen Biotech, Inc. | 4 | $71 |
Products named: Trodelvy, KEYTRUDA, IMBRUVICA, SARCLISA, Enhertu, IBRANCE, VERZENIO, DARZALEX.
Industry payments across MO — which companies pay providers there.
